Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CVR Medical Corp. (CRRVF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00030.0000 (0.00%)
At close: 12:12PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0003
Open0.0003
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0003 - 0.0003
52 Week Range0.0000 - 0.0115
Volume7,500
Avg. Volume45
Market Cap4.633M
Beta (5Y Monthly)-0.15
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CRRVF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CVR MEDICAL CORP
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
  • Newsfile

    CVR Medical Corp. Announces Amended Restructuring Agreement with CVR Global, Inc.

    Vancouver, British Columbia--(Newsfile Corp. - December 20, 2022) - CVR Medical Corp. (TSXV: CVM.H) (OTC: CRRVF) ("CVR Medical" or the "Company" or "we") a Canadian listed and US based healthcare company in the medical device market is pleased to announce an agreement with CVR Global Inc. The 2018 Restructuring Agreement between CVR Medical Corp. and CVR Global Inc. is being amended in favor of a "New" Restructuring Agreement dated November 16, 2022. Pursuant to ...

  • Newsfile

    CVR Medical Corp. Announces Completion of 2022 3rd Quarter Financial Statement

    Vancouver, British Columbia--(Newsfile Corp. - December 1, 2022) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical" or the "Company" or "we") a Canadian listed and US based healthcare company in the medical device market is pleased to announce the completion and filing of its 2022 Q3 Financial Statement. The financial report is posted on SEDAR. About CVR MedicalCVR Medical Corp. is a healthcare company that operates in the medical device industry ...

Advertisement
Advertisement